Back to Journals » Breast Cancer: Targets and Therapy » Volume 6 » default

Breast Cancer: Targets and Therapy


Archive: Volume 6, 2014

Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer

Opdenaker LM, Arnold KM, Pohlig RT, Padmanabhan JS, Flynn DC, Sims-Mourtada J

Breast Cancer: Targets and Therapy 2014, 6:205-209

Published Date: 12 December 2014

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

Haxho F, Allison S, Alghamdi F, Brodhagen L, Kuta VE, Abdulkhalek S, Neufeld RJ, Szewczuk MR

Breast Cancer: Targets and Therapy 2014, 6:191-203

Published Date: 9 December 2014

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

Larsen S, Butthongkomvong K, Manikhas A, Trishkina E, Poddubuskaya E, Matrosova M, Srimuninnimit V, Lindkær-Jensen S

Breast Cancer: Targets and Therapy 2014, 6:179-189

Published Date: 27 November 2014

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer

Stenehjem DD, Yoo M, Unni SK, Singhal M, Bauer H, Saverno K, Quah C, Masaquel A, Brixner DI

Breast Cancer: Targets and Therapy 2014, 6:169-177

Published Date: 29 October 2014

Recent advances in the development of breast cancer vaccines

Milani A, Sangiolo D, Aglietta M, Valabrega G

Breast Cancer: Targets and Therapy 2014, 6:159-168

Published Date: 14 October 2014

Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy

Bayoumi Y, AbdelSamie A, Abdelsaid A, Radwan A

Breast Cancer: Targets and Therapy 2014, 6:151-158

Published Date: 10 September 2014

Effects of switching from anastrozole to letrozole, due to reimbursement policy, on the outcome of breast cancer therapy

Aphinives P, Vachirodom D, Thanapaisal C, Rangsrikajee D, Somintara O

Breast Cancer: Targets and Therapy 2014, 6:145-150

Published Date: 27 August 2014

Breast carcinomas: variations in sonoelastographic appearance

Fleury E, Assunção-Queiroz M, Roveda Jr D

Breast Cancer: Targets and Therapy 2014, 6:135-143

Published Date: 4 August 2014

Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer

Wohlrab J, Bangemann N, Kleine-Tebbe A, Thill M, Kümmel S, Grischke EM, Richter R, Seite S, Lüftner D

Breast Cancer: Targets and Therapy 2014, 6:115-122

Published Date: 1 August 2014

The role of peroxiredoxin II in chemoresistance of breast cancer cells

Wang T, Diaz AJG, Yen Y

Breast Cancer: Targets and Therapy 2014, 6:73-80

Published Date: 23 May 2014

Current strategies for the prevention of breast cancer

Advani P, Moreno-Aspitia A

Breast Cancer: Targets and Therapy 2014, 6:59-71

Published Date: 2 May 2014

Tamoxifen for women at high risk of breast cancer

Nazarali SA, Narod SA

Breast Cancer: Targets and Therapy 2014, 6:29-36

Published Date: 17 February 2014

Multidrug-resistant breast cancer: current perspectives

Martin HL, Smith L, Tomlinson DC

Breast Cancer: Targets and Therapy 2014, 6:1-13

Published Date: 10 January 2014